Biological activity of recently discovered halogenated marine natural products

GW Gribble - Marine drugs, 2015 - mdpi.com
This review presents the biological activity—antibacterial, antifungal, anti-parasitic, antiviral,
antitumor, antiinflammatory, antioxidant, and enzymatic activity—of halogenated marine …

Natural products to drugs: natural product derived compounds in clinical trials

MS Butler - Natural product reports, 2005 - pubs.rsc.org
Covering: 31st December 2004Natural product and natural product-derived compounds that
are being evaluated in clinical trials or in registration (current 31 December 2004) have …

Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor

BG Livett, DW Sandall, D Keays, J Down, KR Gayler… - Toxicon, 2006 - Elsevier
Pain therapeutics discovered by molecular mining of the expressed genome of Australian
predatory cone snails are providing lead compounds for the treatment of neurological …

Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors

C W. Gruber, M Muttenthaler… - Current pharmaceutical …, 2010 - benthamdirect.com
G protein-coupled receptors (GPCRs) are considered to represent the most promising drug
targets; it has been repeatedly said that a large fraction of the currently marketed drugs elicit …

Conotoxins as research tools and drug leads

CJ Armishaw, PF Alewood - Current Protein and Peptide …, 2005 - ingentaconnect.com
The complex mixture of biologically active peptides that constitute the venom of Conus
species provides a rich source of ion channel neurotoxins. These peptides, commonly …

Synthesis and biological evaluation of nonpeptide mimetics of ω-conotoxin GVIA

JB Baell, PJ Duggan, SA Forsyth, RJ Lewis… - Bioorganic & medicinal …, 2004 - Elsevier
A benzothiazole-derived compound (4a) designed to mimic the Cα–Cβ bond vectors and
terminal functionalities of Lys2, Tyr13 and Arg17 in ω-conotoxin GVIA was synthesised …

Strategies for the development of conotoxins as new therapeutic leads

RM Brady, JB Baell, RS Norton - Marine drugs, 2013 - mdpi.com
Peptide toxins typically bind to their target ion channels or receptors with high potency and
selectivity, making them attractive leads for therapeutic development. In some cases the …

Methods for the synthesis of two or more dicarba bridges in organic compounds

A Robinson, RW Jackson, J Patel, J Elaridi - US Patent 7,538,190, 2009 - Google Patents
US7538190B2 - Methods for the synthesis of two or more dicarba bridges in organic
compounds - Google Patents US7538190B2 - Methods for the synthesis of two or more dicarba …

Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides

A Robinson, J Elaridi - US Patent 7,745,573, 2010 - Google Patents
US7745573B2 - Conotoxin analogues and methods for synthesis of intramolecular dicarba
bridge-containing peptides - Google Patents US7745573B2 - Conotoxin analogues and …

Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads

CJ Armishaw - Toxins, 2010 - mdpi.com
α-Conotoxins are peptide neurotoxins isolated from venomous marine cone snails that are
potent and selective antagonists for different subtypes of nicotinic acetylcholine receptors …